Corporate Member Update: Immunomedics-Trodelvy

Corporate Member Update: Immunomedics-Trodelvy

Trodelvy (Sacituzumab govitecan-hziy)
December, 2020


Our corporate sponsor, Immunomedics (now Gilead) has provided the following update for all of our members.

There is a new Permanent J Code for Trodelvy (Sacituzumab govitecan-hziy) that goes into effect on January 1, 2021. Please see the image below, or feel free to visit

https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/2021-asp-drug-pricing-files for more information.

J9317   Sacituzumab govitecan-hziy 2.5 MG 29.505

 

 

 

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members